Kimia Biosciences (BOM:530313) FCF Yield %: 0.00 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
23 GF Score
Price ₹33.04
View Full Analysis

What is Kimia Biosciences FCF Yield %?

Kimia Biosciences BOM:530313 -0.78% 23 FCF Yield % is 0.00 as of Jul. 17, 2026. GuruFocus rates BOM:530313 with a GF Score™ of 23/100. Among 1,007 Drug Manufacturers companies, Kimia Biosciences ranks worse than 99304.77% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kimia Biosciences's Trailing 12-Month Free Cash Flow is ₹0.00 Mil, and Market Cap is ₹1,563.21 Mil. Therefore, Kimia Biosciences's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Kimia Biosciences's FCF Yield % or its related term are showing as below:


BOM:530313's FCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.71
* Ranked among companies with meaningful FCF Yield % only.

Kimia Biosciences's FCF Margin % for the quarter that ended in . 20 was 0.00%.

Kimia Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kimia Biosciences FCF Yield % Related Terms

Kimia Biosciences FCF Yield % Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences FCF Yield % Chart

Kimia Biosciences Annual Data
Trend
FCF Yield %

Kimia Biosciences Semi-Annual Data
FCF Yield %

BOM:530313 vs ZTS, UTHR: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's FCF Yield % falls into.


BOM:530313
23GF Score
Kimia Biosciences Ltd BOM:530313
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kimia Biosciences's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
= /
=N/A%

Kimia Biosciences's annualized FCF Yield % for the quarter that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
= * 1 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
Kimia Biosciences (BOM:530313) has a FCF Yield % of 0.00 as of Jul. 17, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kimia Biosciences and its competitors. According to the industry distribution chart, Kimia Biosciences ranks #999999 out of 1007 companies in the Drug Manufacturers industry.
Is Kimia Biosciences' FCF Yield % too high?
Kimia Biosciences' current FCF Yield % is 0.00. Based on the distribution chart, Kimia Biosciences ranks #999999 out of 1007 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kimia Biosciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Kimia Biosciences' FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kimia Biosciences ranks #999999 out of 1007 companies for FCF Yield %. This places Kimia Biosciences in the lower half of its industry. The industry median FCF Yield % is 0.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.71, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kimia Biosciences and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kimia Biosciences's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kimia Biosciences stock overvalued right now?
Kimia Biosciences (BOM:530313) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Kimia Biosciences' overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Kimia Biosciences (BOM:530313), the current FCF Yield % is 0.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
23GF Score

Get the complete analysis for BOM:530313

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.04
Price